REFRESH EYE ALLERGY RELIEF DIN 02315890
Status: Cancelled Post Market
Holder: ABBVIE CORPORATION
Molecule: ANTAZOLINE PHOSPHATE
Available to quote
Health Canada record
| Active ingredient(s) | ANTAZOLINE PHOSPHATE 0.51 %; NAPHAZOLINE HYDROCHLORIDE 0.051 % |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | NON-PRESCRIPTION DRUGS |
| Class | Human |
| ATC | S01GA51 NAPHAZOLINE, COMBINATIONS |
| Original market date | 09-Feb-2009 |
| Current status date | 11-Nov-2025 |
| Source | Health Canada DPD |
Establishment licence of the holder
AbbVie Corporation — licence 101988, currently licensed, last inspection rating C (2023-07-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ANTAZOLINE PHOSPHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00042641 | ZINCFRIN A | ALCON CANADA INC | Drops | ANTAZOLINE PHOSPHATE 0.5 %; NAPHAZOLINE HYDROCHLORIDE 0.05 %; ZINC SULFATE 0.125 % | Cancelled Post Market |
International API supply for ANTAZOLINE PHOSPHATE
1 active FDA Drug Master Files.
Request a quote for REFRESH EYE ALLERGY RELIEF